Abstract
R&D laboratories are co-ordinating the analysis of increasing volumes of
disparate biological data, largely comprised of gene and protein sequences.
Bioinformatics-enabled data management has enabled companies to improve
productivity within their R&D programmes by identifying new drug targets,
diagnostic biomarkers and biomarkers of drug efficacy and toxicity. From a
systems biology approach, bioinformatics combine data into interactive models
to highlight disease pathways and aid the discovery of on off-target effects
of compounds. Knowledge management solutions are crucial in both instances,
enabling project teams to make informed decisions about potential new drugs.
‘Innovations in Bioinformatics’ is a new report published by
Business Insights that provides a detailed analysis of bioinformatic
developments and applications. This report examines the bioinformatic tools
used to manage high-throughput data from omic technologies, systems biology
modelling and biomarker discovery. Knowledge management solutions are reviewed
and the provisions of major bioinformatics contributors are highlighted. This
report also provides forecasts for bioinformatic tools and services to 2011.
Use this new report to identify the latest developments in bioinformatics,
assess the tools and platforms that can improve drug developments and
benchmark effective implementation strategies.
| 
View Cart
